An A4-sized pharmaceutical promotional flyer developed for Sitagliptin/Metformin Sandoz XR, a combination therapy used in the management of type 2 diabetes mellitus. The flyer is designed to communicate key product information, treatment benefits, and prescribing support for healthcare professionals, highlighting the extended-release (XR) formulation that combines sitagliptin and metformin in a convenient once-daily treatment option. Sitagliptin/Metformin Sandoz XR is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes.

Leadtime:

• Production: 3-4 working days
• Delivery 3-6 working days